This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Prescriber check in with sleep medicine specialist on their impression of Quviviq (daridorexant) in treating Insomnia

Ticker(s): IDRSF

Who's the expert?

Institution: Columbia University

  • Professor of Neurology, College of Physicians and Surgeons at Columbia University, Division of Epilepsy and Sleep Disorders
  • Research interests are primarily in developing novel treatments for refractory epilepsy, and in the interactions between epilepsy, sleep, and sleep disorders.
  • Has published over 100 articles in professional journals, has published books on epilepsy, sleep and epilepsy and has contributed over 20 chapters to various texts in his field.

Interview Goal
.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.